HSCS Stock Performance, Insider Transaction and News

HSCS - Heart Test Laboratories, Inc.

Market Cap	9.22M	P/E	-	EPS this Y	55.50%	Ern Qtrly Grth	-
Income	-6.61M	Forward P/E	-0.61	EPS next Y	25.60%	50D Avg Chg	-7.00%
Sales	18.6k	PEG	-	EPS past 5Y	-	200D Avg Chg	-29.00%
Dividend	N/A	Price/Book	38.70	EPS next 5Y	-	52W High Chg	-79.00%
Recommedations	2.00	Quick Ratio	3.32	Shares Outstanding	0.91M	52W Low Chg	25.00%
Insider Own	11.36%	ROA	-61.63%	Shares Float	766.78K	Beta	3.16
Inst Own	1.20%	ROE	-175.02%	Shares Shorted/Prior	39.70K/43.38K	Price	0.89
Gross Margin	67.31%	Profit Margin	-	Avg. Volume	70,109	Target Price	13.50
Oper. Margin	-33,901.99%	Earnings Date	-	Volume	11,859	Change	-2.05%

Healthcare | Medical Devices | United States

About Heart Test Laboratories, Inc.

Heart Test Laboratories, Inc., doing business as HeartSciences, is a medical technology company focuses on applying AI-based technology to an ECG to expand and improve an ECG's clinical utility. It is developing AI-ECG solutions, a proprietary algorithm designed to detect impaired cardiac relaxation, or cardiac dysfunction, caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG, a resting 12-lead ECG that will incorporate its AI-ECG algorithm that provides diagnostic information related to cardiac dysfunction and conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company is doing business as HeartSciences. Heart Test Laboratories, Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.

Heart Test Laboratories, Inc. News

09/12/24	HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results
09/12/24	HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission
07/29/24	HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results
07/26/24	Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency
07/25/24	HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare
07/11/24	HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction
06/04/24	HeartSciences Regains Compliance with Nasdaq Listing Requirements
05/20/24	HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio
04/24/24	HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG
04/02/24	HeartSciences to Present at the LD Micro Invitational XIV Conference
03/26/24	HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
08:44 AM	Heart Test Laboratories Third Quarter 2024 Earnings: US$0.031 loss per share (vs US$0.16 loss in 3Q 2023)
03/14/24	HeartSciences Reports Third Quarter Fiscal 2024 Financial Results
03/12/24	HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes
03/06/24	HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology
02/26/24	HeartSciences Adds Key Advisor to its Scientific Advisory Board
02/12/24	HeartSciences Expands its Scientific Advisory Board
02/01/24	HeartSciences Appoints New Scientific Advisory Board Member
01/18/24	HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting
01/03/24	HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting

HSCS Chatroom

Beginner999 Posted - 1 hour ago

$HSCS very interesting

Apharmacy84 Posted - 2 hours ago

$HSCS Accumulation mode.

arcadiain Posted - 8 hours ago

$HSCS https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=HSCS

RollingDollars Posted - 3 days ago

$HSCS

Himel92 Posted - 3 days ago

The Last month Performance for $HSCS Opening Price: $3.28 Closing Price: $2.79 Highest Price: $3.85 Lowest Price: $2.36 Percentage Change: -14.89% Data analyst: AITX

StocksSchmocks Posted - 3 days ago

$HSCS making moves 💥💥

Gangal Posted - 3 days ago

$HSCS FDA 510(k) submission for MyoVista wavECG device planned for Q1 2025 Why so long? What they are doing? They said before first half of 2024! What will happen with the SP? Driving it down to 1$?

Gangal Posted - 3 days ago

$HSCS HeartSciences (Nasdaq: HSCS) reported its Q1 FY2025 financial results and provided a business update. Key highlights include: Progress on MyoVista wavECG device and MyoVista Insights cloud platform Cash and cash equivalents of $4.3 million and shareholder's equity of $5.9 million Secured $1.9 million in non-dilutive financing post-quarter end MyoVista Insights AI-ECG algorithm cloud-platform on track for completion by end of 2024 FDA 510(k) submission for MyoVista wavECG device planned for Q1 2025 No revenues reported for Q1 FY2025 The company is developing both cloud and device-based AI-ECG solutions, aiming to transform heart disease detection across various healthcare settings.

DonCorleone77 Posted - 4 days ago

$HSCS Heart Test Laboratories announces financing, with $1.9M in net proceeds Heart Test Laboratories announced the close of a non-dilutive financing, with $1.9 million in net proceeds. The unsecured loan note has an 18-month maturity date and follows the recent 12-month extension of a $500,000 loan note to September 2025. Andrew Simpson, CEO of HeartSciences, said, "We have extended our capital runway by $2.4 million since late August ahead of our upcoming FDA submissions. This has been achieved with non-dilutive capital and provides significant opportunity for HeartSciences to hit a number of valuable commercial milestones."

Stock_Titan Posted - 4 days ago

$HSCS $HSCSW HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results https://www.stocktitan.net/news/HSCS/heart-sciences-provides-business-update-and-reports-first-quarter-5gmltar9hv99.html

Apharmacy84 Posted - 4 days ago

$HSCS 8K says the interest rate on the loan is 12%. Simpson and Hilz have to look for loan shark for money since no legit institution will loan them any capital. lol..

Stocklife978 Posted - 4 days ago

$HSCS all day long just to recover from the dumpers lol

DividendsRUs Posted - 4 days ago

$HSCS Starting to push!

_www_larval_com_ Posted - 4 days ago

$HSCS just shot 5% higher to 3% (~2Mv) a few minutes ago, follow for more volatility.

YungnredE Posted - 4 days ago

$HSCS Just not a good day for penny stocks. The big boys like SPY TSLA NVDA are the ones moving this week.

arcadiain Posted - 4 days ago

$HSCS Tomorrow or in the next few days they will dump and drive it down to $2, disappointing as it seems.

gapureau Posted - 4 days ago

$HSCS Because all stocks nowadays "drop" after news comes out. "Almost" never fails. Really not trying to be flippant (good word, look it up), but it is true.